A team of scientists led by Cardiff University, including Professor Linden, is embarking on a major four-year study to test whether a technique known as Neurofeedback is an effective additional form of treatment for people suffering with mental and behavioural disorders including: autism, alcohol addiction, post-traumatic stress disorder, and eating disorders.
Previous studies have already suggested that this technique might help people with depression and Parkinson’s disease improve their symptoms.
“Self-regulation of brain activity in humans based on real-time feedback of brain imaging signals is emerging as a powerful new technique,” according to Professor Linden, who will co-ordinate the €5.9M European Commission funded BRAINTRAIN consortium alongside neuroscientists, physicists, psychiatrists and computer scientists from the Netherlands, France, Portugal, Germany, Israel and the UK.
“Using an MRI scanner, Neurofeedback allows scientists to monitor brain activity of patents in real-time. The activity levels are then fed back to the patient in the form of a simple display on a screen.
“Using the feedback, it allows patients to see and alter activity in specific parts of their brain. Previous studies have already suggested that this technique might help people with depression and Parkinson’s disease improve their symptoms.”
The project will bring together teams from academia and industry and explore the feasibility in a number of mental and behavioural disorders – specifically characterised by dysfunctional brain systems for motivation, emotion regulation and social communication.
Professor Linden adds: “By bringing together some of the world’s best scientists in the field we will explore and refine real-time functional neuroimaging and find out whether they can be used to train patients to regulate their own brain activity.
“We want to establish whether it can help restore function, improve symptoms and promote resilience.
“Ultimately we hope to establish whether this new technique could become a part of comprehensive treatment programmes for these conditions.”